Translational analyses of ATR inhibitor M1774 in a Phase I study in patients with solid tumors (DDRiver Solid Tumors 301)

被引：3
|
作者：
Tolcher, Anthony W.
Yap, Timothy A.
Plummer, Ruth
Grombacher, Thomas
Wang, Danyi
Schaffroth, Corinna
Hicking, Christine
Szucs, Zoltan
Locatelli, Giuseppe
de Bono, Johann S.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT271
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT271
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Pharmacodynamic and immunophenotyping analyses of ATR inhibitor M1774 in a Phase I study in patients with solid tumors (DDRiver Solid Tumors 301)
    Plummer, Ruth
    Tolcher, Anthony W.
    Yap, Timothy A.
    Sessa, Giuseppe
    Mukker, Jatinder K.
    Seithel-Keuth, Annick
    Hicking, Christine
    Szucs, Zoltan
    Gounaris, Ioannis
    Locatelli, Giuseppe
    de Bono, Johann S.
    CANCER RESEARCH, 2023, 83 (08)
  • [2] A phase I study of ATR inhibitor M1774 in patients with solid tumours (DDRiver Solid Tumours 301): Part A1 results
    Yap, T. A.
    Tolcher, A. W.
    Plummer, R.
    Mukker, J.
    Enderlin, M.
    Hicking, C.
    Locatelli, G.
    Szucs, Z.
    Gounaris, I.
    de Bono, J. S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S747 - S748
  • [3] A first-in-human phase I study of ATR inhibitor M1774 in patients with solid tumors.
    Yap, Timothy A.
    Tolcher, Anthony W.
    Plummer, Elizabeth Ruth
    Becker, Andreas
    Fleuranceau-Morel, Patricia
    Goddemeier, Thomas
    Locatelli, Giuseppe
    Gounaris, Ioannis
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors
    Yap, Timothy A.
    Tolcher, Anthony W.
    Plummer, Ruth
    Mukker, Jatinder Kaur
    Enderlin, Marta
    Hicking, Christine
    Grombacher, Thomas
    Locatelli, Giuseppe
    Szucs, Zoltan
    Gounaris, Ioannis
    de Bono, Johann S.
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2057 - 2067
  • [5] Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors
    Thomas, Anish
    Redon, Christophe E.
    Sciuto, Linda
    Padiernos, Emerson
    Ji, Jiuping
    Lee, Min-Jung
    Yuno, Akira
    Lee, Sunmin
    Zhang, Yiping
    Tran, Lan
    Yutzy, William
    Rajan, Arun
    Guha, Udayan
    Chen, Haobin
    Hassan, Raffit
    Alewine, Christine C.
    Szabo, Eva
    Bates, Susan E.
    Kinders, Robert J.
    Steinberg, Seth M.
    Doroshow, James H.
    Aladjem, Mirit I.
    Trepel, Jane B.
    Pommier, Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (16) : 1594 - +
  • [6] A first-in-human phase I study of the ATM inhibitor M4076 in patients with advanced solid tumors (DDRiver Solid Tumors 410): Part 1A results
    Siu, Lillian L.
    Yap, Timothy A.
    Genta, Sofia
    Pennock, Gregory
    Hicking, Christine
    You, Xiaoli
    Mukker, Jatinder K.
    Locatelli, Giuseppe
    Tolcher, Anthony W.
    CANCER RESEARCH, 2023, 83 (08)
  • [7] Phase I and translational study of capecitabine, cisplatin, and irinotecan in patients with solid tumors.
    Verschraegen, CF
    Lee, FC
    Rabinowitz, I
    Mangalik, A
    Jennings, C
    Maestas, A
    Shen, Z
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 155S - 155S
  • [8] PHASE I STUDY OF RESMINOSTAT, AN ORAL HDAC INHIBITOR, IN JAPANESE PATIENTS WITH SOLID TUMORS
    Kitazono, Satoru
    Fujiwara, Yutaka
    Nakamichi, Shinji
    Mizugaki, Hidenori
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Yamada, Yasuhide
    Tamura, Tomohide
    ANNALS OF ONCOLOGY, 2014, 25
  • [9] Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors
    Ready, Neal E.
    Lipton, Alan
    Zhu, Yali
    Statkevich, Paul
    Frank, Emily
    Curtis, Dolores
    Bukowski, Ronald M.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 576 - 583
  • [10] Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors
    Mross, Klaus
    Stefanic, Martin
    Gmehling, Daniela
    Frost, Annette
    Baas, Franziska
    Unger, Clemens
    Strecker, Ralph
    Henning, Juergen
    Gaschler-Markefski, Birgit
    Stopfer, Peter
    de Rossi, Lothar
    Kaiser, Rolf
    CLINICAL CANCER RESEARCH, 2010, 16 (01) : 311 - 319
12345